{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T05:05:36Z","timestamp":1781499936227,"version":"3.54.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2017,2,10]],"date-time":"2017-02-10T00:00:00Z","timestamp":1486684800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1245\/s10434-017-5803-9","type":"journal-article","created":{"date-parts":[[2017,2,10]],"date-time":"2017-02-10T15:21:42Z","timestamp":1486740102000},"page":"1997-2005","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Isolated Limb Perfusion for Melanoma is Safe and Effective in Elderly Patients"],"prefix":"10.1245","volume":"24","author":[{"given":"Max F.","family":"Madu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion M.","family":"Deken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos A.","family":"van der Hage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarzyna","family":"J\u00f3\u017awiak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel W. J. M.","family":"Wouters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander C. J.","family":"van Akkooi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,2,10]]},"reference":[{"issue":"2","key":"5803_CR1","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1245\/s10434-014-4100-0","volume":"22","author":"RL Read","year":"2015","unstructured":"Read RL, Haydu L, Saw RP, Quinn MJ, Shannon K, Spillane AJ, et al. In-transit melanoma metastases: incidence, prognosis, and the role of lymphadenectomy. Ann Surg Oncol. 2015;22(2):475\u201381.","journal-title":"Ann Surg Oncol."},{"issue":"13","key":"5803_CR2","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1056\/NEJMoa060992","volume":"355","author":"DL Morton","year":"2006","unstructured":"Morton DL, Thompson JF, Cochran AJ, Mozzillo N, Elashoff R, Essner R, et al. Sentinel-node biopsy or nodal observation in melanoma. N Engl J Med. 2006;355(13):1307\u201317.","journal-title":"N Engl J Med."},{"key":"5803_CR3","doi-asserted-by":"crossref","unstructured":"Grunhagen DJ, Kroon HM, Verhoef C. Perfusion and infusion for melanoma in-transit metastases in the era of effective systemic therapy. Am Soc Clin Oncol Educ Book. 2015:e528\u201334.","DOI":"10.14694\/EdBook_AM.2015.35.e528"},{"issue":"4","key":"5803_CR4","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1002\/jso.23558","volume":"109","author":"OE Nieweg","year":"2014","unstructured":"Nieweg OE, Kroon BB. Isolated limb perfusion with melphalan for melanoma. J Surg Oncol. 2014;109(4):332\u20137.","journal-title":"J Surg Oncol."},{"issue":"4","key":"5803_CR5","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1634\/theoncologist.2009-0325","volume":"15","author":"D Moreno-Ramirez","year":"2010","unstructured":"Moreno-Ramirez D, de la Cruz-Merino L, Ferrandiz L, Villegas-Portero R, Nieto-Garcia A. Isolated limb perfusion for malignant melanoma: systematic review on effectiveness and safety. Oncologist. 2010;15(4):416\u201327.","journal-title":"Oncologist."},{"issue":"36","key":"5803_CR6","doi-asserted-by":"crossref","first-page":"6199","DOI":"10.1200\/JCO.2009.23.4799","volume":"27","author":"CM Balch","year":"2009","unstructured":"Balch CM, Gershenwald JE, Soong SJ, Thompson JF, Atkins MB, Byrd DR, et al. Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol. 2009;27(36):6199\u2013206.","journal-title":"J Clin Oncol."},{"issue":"5","key":"5803_CR7","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1245\/ASO.2004.04.032","volume":"11","author":"EM Noorda","year":"2004","unstructured":"Noorda EM, Takkenberg B, Vrouenraets BC, Nieweg OE, van Geel BN, Eggermont AM, et al. Isolated limb perfusion prolongs the limb recurrence-free interval after several episodes of excisional surgery for locoregional recurrent melanoma. Ann Surg Oncol. 2004;11(5):491\u20139.","journal-title":"Ann Surg Oncol."},{"issue":"10","key":"5803_CR8","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1007\/BF02574514","volume":"9","author":"EM Noorda","year":"2002","unstructured":"Noorda EM, Vrouenraets BC, Nieweg OE, van Geel AN, Eggermont AM, Kroon BB. Safety and efficacy of isolated limb perfusion in elderly melanoma patients. Ann Surg Oncol. 2002;9(10):968\u201374.","journal-title":"Ann Surg Oncol."},{"issue":"3","key":"5803_CR9","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.ejso.2005.10.009","volume":"32","author":"EM Noorda","year":"2006","unstructured":"Noorda EM, Vrouenraets BC, Nieweg OE, van Geel AN, Eggermont AM, Kroon BB. Repeat isolated limb perfusion with TNFalpha and melphalan for recurrent limb melanoma after failure of previous perfusion. Eur J Surg Oncol. 2006;32(3):318\u201324.","journal-title":"Eur J Surg Oncol."},{"issue":"11","key":"5803_CR10","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1001\/archsurg.139.11.1237","volume":"139","author":"EM Noorda","year":"2004","unstructured":"Noorda EM, Vrouenraets BC, Nieweg OE, van Geel BN, Eggermont AM, Kroon BB. Isolated limb perfusion for unresectable melanoma of the extremities. Arch Surg. 2004;139(11):1237\u201342.","journal-title":"Arch Surg."},{"issue":"6","key":"5803_CR11","first-page":"564","volume":"178","author":"JM Klaase","year":"1994","unstructured":"Klaase JM, Kroon BB, van Geel AN, van Wijk J, Franklin HR, Eggermont AM, et al. Limb recurrence-free interval and survival in patients with recurrent melanoma of the extremities treated with normothermic isolated perfusion. J Am Coll Surg. 1994;178(6):564\u201372.","journal-title":"J Am Coll Surg."},{"issue":"Suppl 1","key":"5803_CR12","first-page":"13","volume":"4","author":"JM Klaase","year":"1994","unstructured":"Klaase JM, Kroon BB, van Geel AN, Eggermont AM, Franklin HR, van Dongen JA. Is there an indication for a double perfusion schedule with melphalan for patients with recurrent melanoma of the limbs? Melanoma Res. 1994;4 Suppl 1:13\u20136.","journal-title":"Melanoma Res."},{"issue":"7","key":"5803_CR13","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.1245\/s10434-016-5150-2","volume":"23","author":"LA Dossett","year":"2016","unstructured":"Dossett LA, Ben-Shabat I, Olofsson Bagge R, Zager JS. clinical response and regional toxicity following isolated limb infusion compared with isolated limb perfusion for in-transit melanoma. Ann Surg Oncol. 2016;23(7):2330\u20135.","journal-title":"Ann Surg Oncol."},{"issue":"Suppl 3","key":"5803_CR14","doi-asserted-by":"crossref","first-page":"S356","DOI":"10.1245\/s10434-015-4856-x","volume":"22","author":"HG Smith","year":"2015","unstructured":"Smith HG, Cartwright J, Wilkinson MJ, Strauss DC, Thomas JM, Hayes AJ. Isolated limb perfusion with melphalan and tumour necrosis factor alpha for in-transit melanoma and soft tissue sarcoma. Ann Surg Oncol. 2015;22 Suppl 3:S356\u201361.","journal-title":"Ann Surg Oncol."},{"issue":"1","key":"5803_CR15","first-page":"A4741","volume":"61","author":"IF Paulsen","year":"2014","unstructured":"Paulsen IF, Chakera AH, Drejoe JB, Klyver H, Dahlstrom K, Oturai PS, et al. Tumour response after hyperthermic isolated limb perfusion for locally advanced melanoma. Dan Med J. 2014;61(1):A4741.","journal-title":"Dan Med J."},{"issue":"6","key":"5803_CR16","doi-asserted-by":"crossref","first-page":"551","DOI":"10.3109\/02656736.2013.802374","volume":"29","author":"R Olofsson","year":"2013","unstructured":"Olofsson R, Mattsson J, Lindner P. Long-term follow-up of 163 consecutive patients treated with isolated limb perfusion for in-transit metastases of malignant melanoma. Int J Hyperth. 2013;29(6):551\u20137.","journal-title":"Int J Hyperthermia."},{"issue":"11","key":"5803_CR17","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1002\/bjs.7621","volume":"98","author":"JP Deroose","year":"2011","unstructured":"Deroose JP, Grunhagen DJ, van Geel AN, de Wilt JH, Eggermont AM, Verhoef C. Long-term outcome of isolated limb perfusion with tumour necrosis factor-alpha for patients with melanoma in-transit metastases. Br J Surg. 2011;98(11):1573\u201380.","journal-title":"Br J Surg."},{"issue":"2","key":"5803_CR18","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.jamcollsurg.2011.03.013","volume":"213","author":"AK Raymond","year":"2011","unstructured":"Raymond AK, Beasley GM, Broadwater G, Augustine CK, Padussis JC, Turley R, et al. Current trends in regional therapy for melanoma: lessons learned from 225 regional chemotherapy treatments between 1995 and 2010 at a single institution. J Am Coll Surg. 2011;213(2):306\u201316.","journal-title":"J Am Coll Surg."},{"issue":"1","key":"5803_CR19","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1200\/JCO.2009.23.7511","volume":"28","author":"HR Alexander Jr","year":"2010","unstructured":"Alexander HR Jr, Fraker DL, Bartlett DL, Libutti SK, Steinberg SM, Soriano P, et al. Analysis of factors influencing outcome in patients with in-transit malignant melanoma undergoing isolated limb perfusion using modern treatment parameters. J Clin Oncol. 2010;28(1):114\u20138.","journal-title":"J Clin Oncol."},{"issue":"25","key":"5803_CR20","doi-asserted-by":"crossref","first-page":"4196","DOI":"10.1200\/JCO.2005.05.5152","volume":"24","author":"WR Cornett","year":"2006","unstructured":"Cornett WR, McCall LM, Petersen RP, Ross MI, Briele HA, Noyes RD, et al. Randomized multicenter trial of hyperthermic isolated limb perfusion with melphalan alone compared with melphalan plus tumor necrosis factor: American College of Surgeons Oncology Group Trial Z0020. J Clin Oncol. 2006;24(25):4196\u2013201.","journal-title":"J Clin Oncol."},{"issue":"4","key":"5803_CR21","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1002\/jso.23552","volume":"109","author":"HJ Hoekstra","year":"2014","unstructured":"Hoekstra HJ, Veerman K, van Ginkel RJ. Isolated limb perfusion for in-transit melanoma metastases: melphalan or TNF-melphalan perfusion? J Surg Oncol. 2014;109(4):338\u201347.","journal-title":"J Surg Oncol."},{"issue":"7","key":"5803_CR22","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1002\/jso.21949","volume":"104","author":"M Pace","year":"2011","unstructured":"Pace M, Gattai R, Mascitelli EM, Millanta L. Results of isolated lower limb perfusion for loco-regional advanced\/recurrent melanoma using borderline true hyperthermia plus additional bolus of melphalan. A critical analysis of homogeneous cases. J Surg Oncol. 2011;104(7):718\u201323.","journal-title":"J Surg Oncol."},{"issue":"11","key":"5803_CR23","doi-asserted-by":"crossref","first-page":"3000","DOI":"10.1245\/s10434-010-1104-2","volume":"17","author":"CR Rossi","year":"2010","unstructured":"Rossi CR, Pasquali S, Mocellin S, Vecchiato A, Campana LG, Pilati P, et al. Long-term results of melphalan-based isolated limb perfusion with or without low-dose TNF for in-transit melanoma metastases. Ann Surg Oncol. 2010;17(11):3000\u20137.","journal-title":"Ann Surg Oncol."},{"issue":"2","key":"5803_CR24","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1245\/s10434-011-2030-7","volume":"19","author":"JP Deroose","year":"2012","unstructured":"Deroose JP, Eggermont AM, van Geel AN, de Wilt JH, Burger JW, Verhoef C. 20\u00a0years experience of TNF-based isolated limb perfusion for in-transit melanoma metastases: TNF dose matters. Ann Surg Oncol. 2012;19(2):627\u201335.","journal-title":"Ann Surg Oncol."},{"issue":"5","key":"5803_CR25","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1097\/CMR.0000000000000177","volume":"25","author":"JP Deroose","year":"2015","unstructured":"Deroose JP, Grunhagen DJ, Eggermont AM, Verhoef C. Repeated isolated limb perfusion in melanoma patients with recurrent in-transit metastases. Melanoma Res. 2015;25(5):427\u201331.","journal-title":"Melanoma Res."},{"issue":"6","key":"5803_CR26","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1001\/jamasurg.2013.695","volume":"148","author":"ME Lidsky","year":"2013","unstructured":"Lidsky ME, Turley RS, Beasley GM, Sharma K, Tyler DS. Predicting disease progression after regional therapy for in-transit melanoma. JAMA Surg. 2013;148(6):493\u20138.","journal-title":"JAMA Surg."},{"issue":"1","key":"5803_CR27","doi-asserted-by":"crossref","first-page":"16","DOI":"10.3109\/02656730903236086","volume":"26","author":"CE Boesch","year":"2010","unstructured":"Boesch CE, Meyer T, Waschke L, Merkel S, Goehl J, Hohenberger W, et al. Long-term outcome of hyperthermic isolated limb perfusion (HILP) in the treatment of locoregionally metastasised malignant melanoma of the extremities. Int J Hyperth. 2010;26(1):16\u201320.","journal-title":"Int J Hyperthermia."},{"issue":"8","key":"5803_CR28","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1245\/s10434-012-2315-5","volume":"19","author":"K Sharma","year":"2012","unstructured":"Sharma K, Beasley G, Turley R, Raymond AK, Broadwater G, Peterson B, et al. Patterns of recurrence following complete response to regional chemotherapy for in-transit melanoma. Ann Surg Oncol. 2012;19(8):2563\u201371.","journal-title":"Ann Surg Oncol."},{"key":"5803_CR29","doi-asserted-by":"crossref","unstructured":"Grunhagen DJ, Brunstein F, Graveland WJ, van Geel AN, de Wilt JH, Eggermont AM. One hundred consecutive isolated limb perfusions with TNF-alpha and melphalan in melanoma patients with multiple in-transit metastases. Ann Surg. 2004;240(6):939\u201347; discussion 47\u20138.","DOI":"10.1097\/01.sla.0000146147.89667.ed"},{"issue":"4","key":"5803_CR30","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1007\/BF02303503","volume":"5","author":"A Brobeil","year":"1998","unstructured":"Brobeil A, Berman C, Cruse CW, De Conti R, Cantor A, Lyman GH, et al. Efficacy of hyperthermic isolated limb perfusion for extremity-confined recurrent melanoma. Ann Surg Oncol. 1998;5(4):376\u201383.","journal-title":"Ann Surg Oncol."},{"issue":"4","key":"5803_CR31","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1002\/jso.23553","volume":"109","author":"HM Kroon","year":"2014","unstructured":"Kroon HM, Huismans AM, Kam PC, Thompson JF. Isolated limb infusion with melphalan and actinomycin D for melanoma: a systematic review. J Surg Oncol. 2014;109(4):348\u201351.","journal-title":"J Surg Oncol."},{"issue":"18","key":"5803_CR32","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1056\/NEJMoa1210093","volume":"367","author":"KT Flaherty","year":"2012","unstructured":"Flaherty KT, Infante JR, Daud A, Gonzalez R, Kefford RF, Sosman J, et al. Combined BRAF and MEK inhibition in melanoma with BRAF V600 mutations. N Engl J Med. 2012;367(18):1694\u2013703.","journal-title":"N Engl J Med."},{"key":"5803_CR33","doi-asserted-by":"crossref","unstructured":"Hodi FS, O\u2019Day SJ, McDermott DF, Weber RW, Sosman JA, Haanen JB, et al. Improved survival with ipilimumab in patients with metastatic melanoma. N Engl J Med. 2010;363(8):711\u201323.","DOI":"10.1056\/NEJMoa1003466"},{"issue":"4","key":"5803_CR34","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1056\/NEJMoa1412082","volume":"372","author":"C Robert","year":"2015","unstructured":"Robert C, Long GV, Brady B, Dutriaux C, Maio M, Mortier L, et al. Nivolumab in previously untreated melanoma without BRAF mutation. N Engl J Med. 2015;372(4):320\u201330.","journal-title":"N Engl J Med."},{"issue":"26","key":"5803_CR35","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1056\/NEJMoa1503093","volume":"372","author":"C Robert","year":"2015","unstructured":"Robert C, Schachter J, Long GV, Arance A, Grob JJ, Mortier L, et al. Pembrolizumab versus Ipilimumab in advanced melanoma. N Engl J Med. 2015;372(26):2521\u201332.","journal-title":"N Engl J Med."},{"issue":"13","key":"5803_CR36","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1056\/NEJMc1509660","volume":"373","author":"J Larkin","year":"2015","unstructured":"Larkin J, Hodi FS, Wolchok JD. Combined nivolumab and ipilimumab or monotherapy in untreated melanoma. N Engl J Med. 2015;373(13):1270\u20131.","journal-title":"N Engl J Med."},{"issue":"3","key":"5803_CR37","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/jnci\/92.3.205","volume":"92","author":"P Therasse","year":"2000","unstructured":"Therasse P, Arbuck SG, Eisenhauer EA, Wanders J, Kaplan RS, Rubinstein L, et al. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst. 2000;92(3):205\u201316.","journal-title":"J Natl Cancer Inst."},{"issue":"10","key":"5803_CR38","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/0277-5379(82)90235-8","volume":"18","author":"J Wieberdink","year":"1982","unstructured":"Wieberdink J, Benckhuysen C, Braat RP, van Slooten EA, Olthuis GA. Dosimetry in isolation perfusion of the limbs by assessment of perfused tissue volume and grading of toxic tissue reactions. Eur J Cancer Clin Oncol. 1982;18(10):905\u201310.","journal-title":"Eur J Cancer Clin Oncol."},{"issue":"2","key":"5803_CR39","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","volume":"240","author":"D Dindo","year":"2004","unstructured":"Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240(2):205\u201313.","journal-title":"Ann Surg."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1245\/s10434-017-5803-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-017-5803-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-017-5803-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,18]],"date-time":"2019-09-18T14:55:30Z","timestamp":1568818530000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1245\/s10434-017-5803-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,10]]},"references-count":39,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2017,7]]}},"alternative-id":["5803"],"URL":"https:\/\/doi.org\/10.1245\/s10434-017-5803-9","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,10]]}}}